“…The sample size of the included studies ranged from 10 to 156 patients, and the mean age of patients ranged from 46.4 to 71.9 years. The intervention duration in the included studies ranged from 2 weeks to 6 months, including 2 weeks for 19 studies [20,27–34,38,40,42,47–52,61], 14–15 days for one study [25], 3 weeks for 12 studies [12,35,37–41,54–59], 4 weeks for 6 studies [21–24,26,43], 6 weeks for 2 studies [11,53], 8 weeks for 1 study [46], 10 weeks for 2 studies [44,45] and 6 months for 1 study [60]. In terms of outcome measures, 42 studies [11,12,20–37,39–61] assessed the motor function of upper extremity by FMA-UE ( n = 24), ARAT ( n = 14), WMFT-T ( n = 14) and WMFT-FAS ( n = 13), and 31 studies [12,20–27,31–40,42,45,48,50,51,53–59] estimated ADL by MAL-QOM ( n = 30), MAL-AOU ( n = 28) and/or FIM ( n = 8).…”